Log in to save to my catalogue

Implementing patient derived organoids in functional precision medicine for patients with advanced c...

Implementing patient derived organoids in functional precision medicine for patients with advanced c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0d8a07fdb2e64fafb7f7082f91aca715

Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer

About this item

Full title

Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer

Publisher

London: BioMed Central Ltd

Journal title

Journal of experimental & clinical cancer research, 2023-10, Vol.42 (1), p.1-281, Article 281

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Patient Derived Organoids (PDOs) emerged as the best technology to develop ex vivo tumor avatars. Whether drug testing on PDOs to identify efficient therapies will bring clinical utility by improving patient survival remains unclear. To test this hypothesis in the frame of clinical trials, PDO technology faces three main challenges to be...

Alternative Titles

Full title

Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0d8a07fdb2e64fafb7f7082f91aca715

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0d8a07fdb2e64fafb7f7082f91aca715

Other Identifiers

ISSN

1756-9966,0392-9078

E-ISSN

1756-9966

DOI

10.1186/s13046-023-02853-4

How to access this item